Balaji Amines Limited announced its un-audited financial results for the quarter and nine months ended December 31st, 2025. For the third quarter of FY26, the consolidated total income stood at ₹336.29 crore, with EBITDA at ₹61.67 crore and Profit After Tax (PAT) at ₹30.76 crore. This compares to a consolidated total income of ₹347.61 crore, EBITDA of ₹66.87 crore, and PAT of ₹37.10 crore in the previous quarter (Q2FY26). On a standalone basis for Q3FY26, total income was ₹306.57 crore, EBITDA was ₹60.07 crore, and PAT was ₹32.42 crore. The company noted that on a standalone basis, it is a zero-debt company. For the nine months ended December 31st, 2025, consolidated total income was ₹1,051.26 crore, EBITDA was ₹192.25 crore, and PAT was ₹104.39 crore. The standalone nine-month figures show a total income of ₹949.39 crore, EBITDA of ₹180.80 crore, and PAT of ₹103.66 crore. Looking ahead, the company provided updates on new projects. The Di Methyl Ether (DME) plant is expected to be commissioned in FY 2026-27. The N-Methyl Morpholine (NMM) plant (5000 TPA) is also expected to be commissioned during FY 2026-27. An improved process based Acetonitrile (ACN) plant is under execution and expected in FY 2026-27. These projects will be funded through internal accruals. Balaji Speciality Chemicals Limited is undertaking a new expansion of ₹750 crore, with Mega Project status granted by the Government of Maharashtra. This expansion includes products like Hydrogen Cyanide (HCN), Sodium Cyanide (NaCN), and Ethylene Diamine Tetra Acetic Acid (EDTA). At Unit-I, a brownfield project for EDA based products is expected in H1FY26-27. At Unit-II (Greenfield Project), plants for HCN, NaCN, EDTA, and EDTA-2Na are expected in Q4 of FY 2026-27. Mr. D. Ram Reddy, Managing Director, commented that while demand trends were softer due to global uncertainties, key projects are advancing. He expressed confidence in a steady pickup in performance as new capacities contribute. The company sees positive export outlook due to the new Free Trade Agreement with the EU. He also noted that legacy amines and derivatives business provide reliable cash flows, and despite near-term utilization challenges for new capacities, structural tailwinds in specialty chemicals are expected to drive growth.
